BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15449047)

  • 1. Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients.
    Violot D; M'Kacher R; Adjadj E; Dossou J; de Vathaire F; Parmentier C
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):174-9. PubMed ID: 15449047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased rate of dicentric chromosomes in French Polynesian thyroid cancer patients?
    Pauwels EK
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):382; author reply 383. PubMed ID: 16292628
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Legal JD; Schlumberger M; Voisin P; Aubert B; Gaillard N; Parmentier C
    J Nucl Med; 1996 Nov; 37(11):1860-4. PubMed ID: 8917193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer.
    Khvostunov IK; Saenko VA; Krylov V; Rodichev A; Yamashita S
    Radiat Environ Biophys; 2017 Aug; 56(3):213-226. PubMed ID: 28526978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of short-term chromosomal damage due to therapeutic 131I exposure in patients with thyroid cancer.
    Hernández-Jardines A; Molina B; del Castillo V; Papadakis M; Rivera T; Azorín J; Herrera LA; Yokoyama E; Frías S
    Rev Invest Clin; 2010; 62(1):31-8. PubMed ID: 20415057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and dosimetric effects of (131)I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments.
    da Silva MA; Valgôde FG; Gonzalez JA; Yoriyaz H; Guimarães MI; Ribela MT; Buchpiguel CA; Bartolini P; Okazaki K
    Radiat Environ Biophys; 2016 Aug; 55(3):317-28. PubMed ID: 27013085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
    Katz N; Esik O; Füzy M; Gundy S
    Orv Hetil; 1998 Jun; 139(25):1521-6. PubMed ID: 9676113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.
    Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Futatsuya R; Michigishi T; Tonami N; Seto H; Goodwin DA
    J Nucl Med; 1998 Mar; 39(3):436-40. PubMed ID: 9529288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Légal JD; Schlumberger M; Aubert B; Beron-Gaillard N; Gaussen A; Parmentier C
    J Nucl Med; 1997 Mar; 38(3):377-80. PubMed ID: 9074522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer.
    Baugnet-Mahieu L; Lemaire M; Léonard ED; Léonard A; Gerber GB
    Radiat Res; 1994 Dec; 140(3):429-31. PubMed ID: 7972697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimation.
    Jentzen W; Moldovan AS; Ruhlmann M; Görges R; Bockisch A; Rosenbaum-Krumme S
    Nuklearmedizin; 2015; 54(3):137-43. PubMed ID: 25987357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased uptake after fractionated ablative doses of iodine-131.
    Wu HS; Hseu HH; Lin WY; Wang SJ; Liu YC
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):167-73. PubMed ID: 15351912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.
    M'Kacher R; Schlumberger M; Légal JD; Violot D; Béron-Gaillard N; Gaussen A; Parmentier C
    J Nucl Med; 1998 May; 39(5):825-9. PubMed ID: 9591584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4 and 10 in thyroid cancer patients treated with radioactive iodine.
    Puerto S; Marcos R; Ramírez MJ; Galofré P; Creus A; Surrallés J
    Mutat Res; 2000 Aug; 469(1):147-58. PubMed ID: 10946251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study.
    Cléro É; Doyon F; Chungue V; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Dewailly E; Rubino C; de Vathaire F
    Thyroid; 2012 Apr; 22(4):422-9. PubMed ID: 22280227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
    Eberlein U; Scherthan H; Bluemel C; Peper M; Lapa C; Buck AK; Port M; Lassmann M
    J Nucl Med; 2016 Feb; 57(2):173-9. PubMed ID: 26564321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid cancer in French Polynesia between 1985 and 1995: influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974.
    de Vathaire F; Le Vu B; Vathaire CC
    Cancer Causes Control; 2000 Jan; 11(1):59-63. PubMed ID: 10680730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior and Food Consumption Pattern of the French Polynesian Population in the 1960s -1970s.
    Drozdovitch V; Bouville A; Tetuanui T; Taquet M; Gardon J; Xhaard C; Ren Y; Doyon F; de Vathaire F
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3667-3677. PubMed ID: 31870108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.